Raffa Wealth Management’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
Other funds holding ALDX
KCM
KCM
6CM
Raffa Wealth Management's ALDX Position: Q3 2026 in Review
Raffa Wealth Management held its Aldeyra Therapeutics (ALDX) position steady in Q3 2026 at 1,897 shares worth $2.33K. The position accounts for ﹤0.01% of the portfolio, ranked #791.
Raffa Wealth Management first reported a position in ALDX in Q4 2024 and has held it in 8 quarters since. The position peaked at $10.9K in Q1 2025. 97 funds tracked by Wall St. Rank hold ALDX as of Q3 2026.
- Raffa Wealth Management held 1,897 shares of Aldeyra Therapeutics worth $2.33K as of Q3 2026.
- Raffa Wealth Management left its Aldeyra Therapeutics share count unchanged in Q3 2026.
- Aldeyra Therapeutics made up ﹤0.01% of Raffa Wealth Management's portfolio in Q3 2026, its #791 holding.
- Raffa Wealth Management first reported a position in Aldeyra Therapeutics in Q4 2024 and has held it in 8 quarters since.
- Raffa Wealth Management's Aldeyra Therapeutics position peaked at $10.9K in Q1 2025.
- 97 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q3 2026.
Based on Raffa Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.